This Texas Company’s Embryo Testing Is The Future Of The Fertility Industry

A new embryo testing alternative has recently been launched. Avrio Genetics’ new method employs non-invasive strategies to deliver accurate screening results and healthier embryos. Go to http://www.AvrioGenetics.com for more info!

Embryo method test Avrio genetic invasive invasive Embryo test test Embryo This clinical

Embryo method test Avrio genetic invasive invasive Embryo test test Embryo This clinical

This Texas Company’s Embryo Testing Is The
Future Of The Fertility Industry
Are you interested in the study of
reproductive endocrinology and
embryology? Are you ready to find out
about the latest advancements in these
fields? If you answered yes to any of
these questions then this new method is
what you need to know about!
Texas based fertility company Avrio
Genetics has recently launched a non-
invasive embryo testing method. This
new method seeks to allow patients that
require in vitro fertilization a safer
alternative to the existing invasive
measures.
It also aims to introduce a
more affordable way to test
embryos for the fertility
industry.
The previous method of testing embryos
involved taking a sample and examining the
cells under a microscope. This method
helps professionals like you determine the
genetic health of the embryo and allows the
one with the highest chance of a successful
pregnancy to be selected.
This method has been seen as
invasive, dangerous, and has
the potential of lowering the
viability of the embryo.
Additionally, it is expensive.
The new method proposed by
Avrio Genetics will provide non-
invasive and cost-effective embryo
screening without disturbing the
embryo and thus lowers the risk of
it losing its viability.
This non-invasive method of testing
embryos is not only safer, but it will
improve clinical outcomes. Concerning
implantation rate, clinical pregnancy,
ongoing pregnancy, and live birth, this
method will allow all clinical progressional
goals to be achieved.
It will save time at the clinical
level and also will provide a
second chance for embryos
that were not initially ideal.
Additionally, the method will allow
labs to have the results released in 24
hours, avoids losses and failures that
could occur during testing, and
improves the performance of the test
using artificial intelligence analytics.
Avrio Genetics aims to launch
additional non-invasive embryo
testing within the next six months
and seeks to deliver services that
align with its CEO's belief system
of a better tomorrow.
Go to
http://www.AvrioGeneti
cs.com for more info!